Aplikacija za spremljanje stranskih učinkov kemoterapije za operacijski sistem iOS

Autor: LEGAT, PRIMOŽ
Přispěvatelé: Kukar, Matjaž
Jazyk: slovinština
Rok vydání: 2023
Předmět:
Popis: OnkoVed (prvotno mPRO Mamma) je obstoječa aplikacija za spremljanje stranskih učinkov kemoterapije, razvita za platformo Android. Nastala je v sodelovanju z Onkološkim inštitutom, kjer so z uporabo aplikacije uspešno izvedli raziskavo o kakovosti življenja pri bolnicah z rakom na dojkah. Tekom raziskave so se pojavile potrebe po dodelavi in spremembi nekaterih funkcionalnosti. V diplomski nalogi proučimo obstoječo aplikacijo, jo razvijemo za drugo najbolj razširjeno mobilno platformo iOS ter nadgradimo z želenimi razširitvami. Aplikacija podpira spremljanje stranskih učinkov, zdravniških pregledov in terapij grafični prikaz podatkov prikaz koristnih povezav vnos osebnih podatkov izbiro vrste raka in tipa uporabnika možnost odgovarjanja na standardizirane vprašalnike možnost nastavitve opomnika in varno deljenje podatkov z izbranim onkologom. Aplikacija se že poskusno uporablja na Onkološkem inštitutu. OnkoVed (formerly mPRO Mamma) is an existing Android application for monitoring chemotherapy side effects. It was developed in collaboration with the Institute of Oncology Ljubljana, where it was used to conduct a research about qualify of life in patients with breast cancer. Throughout the research, feedback was gathered which showed the need for improvement and change to some of the functionalities the application offers. In this thesis we examine the functionalities of the existing application and develop it for the second most popular mobile app platform - iOS. The application supports tracking of side effects during treatment, doctor appointments and therapies graphical visualisation of data presents helpful links supports managing of personal data provides the option choose diagnosed type of cancer supports multiple user types provides standardised questionnaires which the user can answer supports reminders and the option for users to safely share their data with their doctor. The application is experimentally already being used by the Institute of Oncology Ljubljana.
Databáze: OpenAIRE